# The Effect of Peroral Sodium Hyaluronate on the Skin

> **NCT07065110** · NA · COMPLETED · sponsor: **Contipro Pharma a.s.** · enrollment: 150 (actual)

## Conditions studied

- Skin Conditions

## Interventions

- **DIAGNOSTIC_TEST:** Blood draw for the laboratory assessment
- **DIETARY_SUPPLEMENT:** Skin test panel
- **DIETARY_SUPPLEMENT:** HA gel
- **DIETARY_SUPPLEMENT:** Xanthan gum

## Key facts

- **NCT ID:** NCT07065110
- **Lead sponsor:** Contipro Pharma a.s.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-17
- **Primary completion:** 2024-12-13
- **Final completion:** 2024-12-13
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2025-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07065110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07065110, "The Effect of Peroral Sodium Hyaluronate on the Skin". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07065110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*